ReP USP - Resultado da busca

Artigo de periodico
Essential data variables for a minimum dataset for head and neck cancer trials and clinical research: HNCIG consensus recommendations and database (2024)
Baliga, Sujith; Abou-foul, Ahmad K; Parente, Pablo; Szturz, Petr; Thariat, Juliette; Shreenivas, Aditya; Nankivell, Paul; Bertolini, Federica; Biau, Julian; Kowalski, Luiz Paulo
Source: European journal of cancer. Unidade: FM
Subjects: NEOPLASIAS, RADIOTERAPIA, NEOPLASIAS DE CABEÇA E PESCOÇO, CONSENSO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BALIGA, Sujith et al. Essential data variables for a minimum dataset for head and neck cancer trials and clinical research: HNCIG consensus recommendations and database. European journal of cancer, v. 203, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/76775. Acesso em: 19 nov. 2024.
APA
Baliga, S., Abou-foul, A. K., Parente, P., Szturz, P., Thariat, J., Shreenivas, A., et al. (2024). Essential data variables for a minimum dataset for head and neck cancer trials and clinical research: HNCIG consensus recommendations and database. European journal of cancer, 203. doi:10.1016/j.ejca.2024.114038
NLM
Baliga S, Abou-foul AK, Parente P, Szturz P, Thariat J, Shreenivas A, Nankivell P, Bertolini F, Biau J, Kowalski LP. Essential data variables for a minimum dataset for head and neck cancer trials and clinical research: HNCIG consensus recommendations and database [Internet]. European journal of cancer. 2024 ; 203[citado 2024 nov. 19 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76775
Vancouver
Baliga S, Abou-foul AK, Parente P, Szturz P, Thariat J, Shreenivas A, Nankivell P, Bertolini F, Biau J, Kowalski LP. Essential data variables for a minimum dataset for head and neck cancer trials and clinical research: HNCIG consensus recommendations and database [Internet]. European journal of cancer. 2024 ; 203[citado 2024 nov. 19 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76775
Artigo de periodico
Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) (2018)
Giugliano, Robert P.; Nicolau, Jose Carlos
Source: Circulation. Unidade: FM
Subjects: DIABETES MELLITUS, DOENÇAS CARDIOVASCULARES, FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIUGLIANO, Robert P. e NICOLAU, Jose Carlos. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial). Circulation, v. 137, n. 15, p. 1571-0, 2018Tradução . . Disponível em: https://doi.org/10.1161/CIRCULATIONAHA.117.030950. Acesso em: 19 nov. 2024.
APA
Giugliano, R. P., & Nicolau, J. C. (2018). Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial). Circulation, 137( 15), 1571-0. doi:10.1161/CIRCULATIONAHA.117.030950
NLM
Giugliano RP, Nicolau JC. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) [Internet]. Circulation. 2018 ; 137( 15): 1571-0.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1161/CIRCULATIONAHA.117.030950
Vancouver
Giugliano RP, Nicolau JC. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) [Internet]. Circulation. 2018 ; 137( 15): 1571-0.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1161/CIRCULATIONAHA.117.030950
Artigo de periodico
Palliative care in interstitial lung disease: living well (2017)
Kreuter, Michael; Kairalla, Ronaldo Adib
Source: Lancet respiratory medicine. Unidade: FM
Subjects: QUALIDADE DE VIDA, CUIDADOS PALIATIVOS, DOENÇAS PULMONARES INTERSTICIAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KREUTER, Michael e KAIRALLA, Ronaldo Adib. Palliative care in interstitial lung disease: living well. Lancet respiratory medicine, v. 5, n. 12, p. 968-980, 2017Tradução . . Disponível em: https://doi.org/10.1016/S2213-2600(17)30383-1. Acesso em: 19 nov. 2024.
APA
Kreuter, M., & Kairalla, R. A. (2017). Palliative care in interstitial lung disease: living well. Lancet respiratory medicine, 5( 12), 968-980. doi:10.1016/S2213-2600(17)30383-1
NLM
Kreuter M, Kairalla RA. Palliative care in interstitial lung disease: living well [Internet]. Lancet respiratory medicine. 2017 ; 5( 12): 968-980.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/S2213-2600(17)30383-1
Vancouver
Kreuter M, Kairalla RA. Palliative care in interstitial lung disease: living well [Internet]. Lancet respiratory medicine. 2017 ; 5( 12): 968-980.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/S2213-2600(17)30383-1

USP Schools

ReP

Filtros

Authors

Subjects

Funding Agencies